Outcomes Following Delta Xtend Reverse Shoulder System

NCT02014350 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2013-12-18

No results posted yet for this study

Summary

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Conditions

  • Reverse Total Shoulder Arthroplasty

Interventions

DEVICE

DePuy Delta Xtend Reverse TSA

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014350 on ClinicalTrials.gov